D. E. Shaw & Co. Inc. Has $4.20 Million Stake in ZimVie Inc. (NASDAQ:ZIMV)

D. E. Shaw & Co. Inc. grew its stake in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 12.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 301,316 shares of the company's stock after acquiring an additional 32,551 shares during the quarter. D. E. Shaw & Co. Inc. owned 1.09% of ZimVie worth $4,203,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Divisadero Street Capital Management LP bought a new stake in ZimVie in the fourth quarter valued at approximately $418,000. BNP Paribas Financial Markets bought a new position in shares of ZimVie during the fourth quarter worth $416,000. Ancora Advisors LLC grew its holdings in shares of ZimVie by 460.8% in the 4th quarter. Ancora Advisors LLC now owns 112,160 shares of the company's stock valued at $1,565,000 after buying an additional 92,160 shares during the period. Northern Trust Corp grew its holdings in shares of ZimVie by 3.5% in the 4th quarter. Northern Trust Corp now owns 326,252 shares of the company's stock valued at $4,551,000 after buying an additional 10,988 shares during the period. Finally, Mill Road Capital Management LLC bought a new stake in shares of ZimVie in the 4th quarter valued at $1,401,000. 95.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have weighed in on ZIMV shares. UBS Group reduced their target price on ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a report on Thursday, May 15th. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th. Finally, B. Riley assumed coverage on ZimVie in a research note on Thursday, April 10th. They set a "buy" rating and a $16.00 target price for the company.

ZimVie Stock Down 4.1%

ZIMV traded down $0.36 during trading on Wednesday, hitting $8.52. The company had a trading volume of 194,507 shares, compared to its average volume of 213,913. The company has a market capitalization of $237.26 million, a PE ratio of -0.65 and a beta of 2.16. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a one year low of $8.52 and a one year high of $22.40. The firm's 50-day moving average price is $9.81 and its 200 day moving average price is $12.40.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.06. The company had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.10 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. As a group, equities analysts expect that ZimVie Inc. will post 0.6 earnings per share for the current year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.